Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Angela Bialke"'
Autor:
Sandra Bien-Möller, Ellen Balz, Susann Herzog, Laura Plantera, Silke Vogelgesang, Kerstin Weitmann, Carolin Seifert, Matthias A. Fink, Sascha Marx, Angela Bialke, Chitra Venugopal, Sheila K. Singh, Wolfgang Hoffmann, Bernhard H. Rauch, Henry W. S. Schroeder
Publikováno v:
Stem Cells International, Vol 2018 (2018)
Patients with glioblastoma multiforme (GBM) are at high risk to develop a relapse despite multimodal therapy. Assumedly, glioma stem cells (GSCs) are responsible for treatment resistance of GBM. Identification of specific GSC markers may help to deve
Externí odkaz:
https://doaj.org/article/218f53324488424fa91fe360416fe654
Autor:
Sandra Bien-Möller, Henry W.S. Schroeder, Bernhard H. Rauch, Wolfgang Hoffmann, Angela Bialke, Kerstin Weitmann, Silke Vogelgesang, Markus Grube, Susann Herzog, Heiko Paland, Matthias A. Fink
Purpose:Apoptotic dysregulation, redox adaptive mechanisms, and resilience to hypoxia are major causes of glioblastoma (GBM) resistance to therapy. Commonly known as crucial factors in energy metabolism, OCTN2 (SLC22A5) and its substrate L-carnitine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9c0d11a9243b176e0b6ac9be2ba1f18
https://doi.org/10.1158/1078-0432.c.6527738
https://doi.org/10.1158/1078-0432.c.6527738
Autor:
Sandra Bien-Möller, Henry W.S. Schroeder, Bernhard H. Rauch, Wolfgang Hoffmann, Angela Bialke, Kerstin Weitmann, Silke Vogelgesang, Markus Grube, Susann Herzog, Heiko Paland, Matthias A. Fink
Expression and survival analyses of CPT1A and CPT1C in GBM specimens
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23b08599f9604aa85ca5794539ad8068
https://doi.org/10.1158/1078-0432.22470941
https://doi.org/10.1158/1078-0432.22470941
Autor:
Bernhard H. Rauch, Susann Herzog, Henry W. S. Schroeder, Angela Bialke, Silke Vogelgesang, Matthias A. Fink, Heiko Paland, Kerstin Weitmann, Markus Grube, Wolfgang Hoffmann, Sandra Bien-Möller
Publikováno v:
Clinical Cancer Research. 25:2874-2886
Purpose: Apoptotic dysregulation, redox adaptive mechanisms, and resilience to hypoxia are major causes of glioblastoma (GBM) resistance to therapy. Commonly known as crucial factors in energy metabolism, OCTN2 (SLC22A5) and its substrate L-carnitine
Autor:
Bernhard H. Rauch, Silke Vogelgesang, Sheila K. Singh, Sandra Bien-Möller, Chitra Venugopal, Laura Plantera, Wolfgang Hoffmann, Kerstin Weitmann, Henry W. S. Schroeder, Sascha Marx, Angela Bialke, Susann Herzog, Carolin Seifert, Ellen Balz, Matthias A. Fink
Publikováno v:
Stem Cells International, Vol 2018 (2018)
Stem Cells International
Stem Cells International
Patients with glioblastoma multiforme (GBM) are at high risk to develop a relapse despite multimodal therapy. Assumedly, glioma stem cells (GSCs) are responsible for treatment resistance of GBM. Identification of specific GSC markers may help to deve